Latest News about AMGN
Recent news which mentions AMGN
8 Retirement Stocks to Buy for Any Market Conditions
April 06, 2021
From InvestorPlace
Is Silicon Valley Replacing Big Pharma In Neuroscience?
April 06, 2021
From Benzinga
The Latest Picks And Pans From Barron's: Barrick Gold, BioNTech, Facebook, WW And More
April 04, 2021
From Benzinga
Are Ultra-High Drug Prices Sustainable?
April 01, 2021
From Motley Fool
The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO
March 31, 2021
From Benzinga
3 Cheap Stocks to Buy for 2021
March 31, 2021
From Motley Fool
From MarketWatch
Like Dividends? I Bet You'll Love These 3 Stocks
March 28, 2021
From Motley Fool
Write Your Own Stimulus Check Every Month With These Three Dividend-Paying Dow Stocks
March 27, 2021
From Motley Fool
From Motley Fool
From Benzinga
Laryngeal Cancer Therapeutics Market To See $635M Growth By 2025 And These 2 Companies Will Be Key Drivers: Research
March 18, 2021
From Benzinga
Dow scores fastest 1,000-point move in history as it tops 33,000 milestone — here’s what drove it there
March 17, 2021
From MarketWatch
3 Biotech Stocks That Could Double In 12 Months
March 17, 2021
From Benzinga
Barron's Latest Picks And Pans: Apple, Coupang, GameStop, Uber, Walker & Dunlop And More
March 13, 2021
From Benzinga
From Motley Fool
7 Pharmaceutical Stocks Working on Their Next Blockbuster
March 12, 2021
From InvestorPlace
Why You Should Own Biotech Stocks Now
March 11, 2021
From Motley Fool
What Are the Risks of Investing in Biotech Stocks?
March 11, 2021
From Motley Fool
From MarketWatch
The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study
March 05, 2021
From Benzinga
10 Biggest Price Target Changes For Friday
March 05, 2021
From Benzinga
From Motley Fool
Why Five Prime Therapeutics Stock Is Skyrocketing Today
March 04, 2021
From Motley Fool
FPRX Stock: The Huge Takeover News That Has Five Prime Therapeutics Shares Blasting Higher
March 04, 2021
From InvestorPlace
Amgen Pays $1.9B For Five Prime Therapeutics Acquisition
March 04, 2021
From Benzinga
From Motley Fool
The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study
March 03, 2021
From Benzinga
Where Will Pfizer Be in 1 Year?
March 02, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|
|
|
|